Navigation Links
Tango mandarins to appear this month in produce aisles
Date:1/7/2011

for generations. For example, all navel oranges are sports natural mutations of oranges with seeds or other navel oranges.)

Tango is not a trademarked name, so the new seedless mandarin probably will be sold under existing grower brand names like Cuties and Delites. Before Christmas, fruit marketed as Cuties and Delites are early ripening Clementine mandarins. At the discretion of a UC-Tango licensee, the Tango, along with other non-UC mandarin selections, will likely be sold as Cuties and Delites when they ripen later this month, but some Tangos will show up in supermarkets and farmer's markets under the Tango name.

"UC Riverside and the Office of Technology Commercialization are most proud of the Tango mandarin," said Craig Sheward, the assistant vice chancellor for technology commercialization. "This seedless mandarin superior in taste and feverishly being sought out by commercial citrus companies and growers is a wonderful example of UCR's world-class citrus breeding program. We believe the success of Tango will bring ripple benefits to California citrus growers and the people of California who have supported this program."

The Tango was made possible by a UC and citrus industry partnership going back nearly 15 years. Roose and staff research associate Timothy Williams began field testing the fruit in 2001. The research and evaluation program was supported by the Citrus Research Board.

UCR has a long tradition in citrus research, with citrus production and development of new varieties being a major focus. The university is home to the University of California Citrus Variety Collection, consisting of two trees each of more than 1,000 different citrus types. Used extensively to solve citrus disease problems and improve commercial varieties, the collection is one of th
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. It takes 2 to tango
2. Young female chimpanzees appear to treat sticks as dolls
3. Use of omega-3 does not appear to reduce recurrence of atrial fibrillation
4. Newly discovered gene enables fish to disappear
5. Disappearing glaciers enhanced biodiversity
6. Antibiotic appears safe for stroke patients and good companion for tPA
7. Mallory and Irvine: Did extreme weather cause their disappearance?
8. Temperature constancy appears key to tropical biodiversity
9. New research on rapidly disappearing ancient plant offers hope for species recovery
10. New research on rapidly-disappearing ancient plant offers hope for species recovery
11. Invasive tunicate appears in Oregons coastal waters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tango mandarins to appear this month in produce aisles
(Date:5/11/2015)... -- Curemark LLC, a privately held drug research and ... III double blind, randomized, placebo-controlled clinical trial to examine ... children ages 3-8 with Autism. Previously, Curemark announced the ... clinical trial for CM-AT in children ages 3-8 with ... chymotrypsin. This new trial will help determine whether all ...
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, reminds investors and media that  Mr. ...  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of nine ... Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... Although Antarctic krill (Euphausia superba) are one of the ... their life cycle have remained murky. , Understanding krill ... birds, and marine mammals, yet they are vulnerable to ... issue of BioScience, the monthly journal of the American ...
... Division of Cellegy Pharmaceuticals, Inc. today announced a non-exclusive ... the prevention of HIV and other sexually transmitted diseases. ... the agreement are in various stages of development and ... Savvy, which is currently in Phase III clinical trials ...
... five percent of deaths from SIDS (sudden infant death syndrome) ... gene and half of those deaths result from a common ... abnormal heart rhythm during times of environmental stress, a research ... February 2006 issue of the Journal of Clinical Investigation. ...
Cached Biology News:New licensing agreement to maximize AIDS drug development 2Gene variation increases SIDS risk in African Americans 2Gene variation increases SIDS risk in African Americans 3
(Date:6/2/2015)... SAO PAULO , June 2, 2015   ... leader in biosimilars, today announced that its partner, Celltrion – ... ANVISA – the National Health Surveillance Agency in ... first biosimilar monoclonal antibody approved for use in ... by Hospira. Hospira also markets and sells biosimilar infliximab ...
(Date:6/2/2015)... LOUIS , June 2, 2015   ... Life Science and Technology company, announced today it ... Science to launch genetically engineered human neural ... advance the research of neurological diseases. These new ... provide unique and versatile tools for the study ...
(Date:6/2/2015)... June 02, 2015 Through rare discovery ... Yancy Corporation is enabling World Scientists to ... and biological sample, displaying the full nature (position, shape, ... atoms. , Jeff Porter, Co-Founder of the Yancy Corporation, ... that – rare. They come once in a lifetime, ...
(Date:6/1/2015)... June 1, 2015  Turing Pharmaceuticals AG announced that ... Salinas , MD, MSc,  has joined the company ... Dr. Salinas, who holds a medical degree as ... record of significant accomplishments in the pharmaceutical industry, ... Dr. Salinas has played a leadership role in ...
Breaking Biology Technology:ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 3Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3
... CRANBURY, N.J., Aug. 12 Palatin Technologies, Inc. (NYSE ... of a Phase 1 clinical trial of subcutaneously administered ... male erectile dysfunction (ED) and female sexual dysfunction (FSD). ... blood plasma levels can be obtained without blood pressure ...
... Health care jobs continue ... industry remains at 20,000 monthly, and health care has one of the the lowest unemployment rates ... feeling the economic pinch more and more. , ... (Vocus) August 12, 2009 -- There is a dichotomy between simultaneous job creation and job ...
... Scientists drew fittingly from Roman mythology when they named ... Janus, who is usually depicted as having two faces ... been fascinated by the tantalizing possibilities of these particles ... and many other devices. However, realizing these applications requires ...
Cached Biology Technology:Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration 2Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration 3Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration 4The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers 2The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers 3The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers 4Capping a two-faced particle gives duke engineers complete control 2
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Blue Standard is 3-cyano-7-hydroxycoumarin....
Biology Products: